Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under award number GM070743-01 and the U.S. National Science Foundation (NSF) . Corporate funding is provided through a contract from Unilever PLC.